AC Immune (ACIU) Tax Provisions (2022 - 2023)
AC Immune (ACIU) posted quarterly Tax Provisions of -$1127.4 for Q4 2023, up 45.7% year-over-year from -$773.77 in Q4 2022, and up 66.81% quarter-over-quarter from -$3396.5 in Q3 2023.
AC Immune (ACIU) Tax Provisions (2022 - 2023) Analysis & Trends
AC Immune (ACIU) has reported Tax Provisions for 2 consecutive years, with -$1127.4 the latest figure, recorded in Q4 2023.
- In Q4 2023, Tax Provisions rose 45.7% year-over-year to -$1127.4; the TTM figure through Dec 2023 stood at -$11103.8 (up 18.74% YoY), while the FY2024 annual figure was -$3424.6, up 69.62% from the prior year.
- Tax Provisions advanced to -$1127.4 in Q4 2023 per ACIU's latest filing, from -$3396.5 in the prior quarter.
- Across five years, Tax Provisions topped out at -$1127.4 in Q4 2023 and bottomed at -$4331.2 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | AC Immune | 253.89 Mn | 253.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -1,127.35 |
| Sep 30, 2023 | -3,396.46 |
| Jun 30, 2023 | -3,336.53 |
| Mar 31, 2023 | -3,243.49 |
| Dec 31, 2022 | -2,076.04 |
| Sep 30, 2022 | -4,141.83 |
| Jun 30, 2022 | -3,114.88 |
| Mar 31, 2022 | -4,331.23 |